Cargando…
Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?
The relationship between the response to chemotherapy with cyclophosphamide, epirubicin and fluorouracil as well as the time to progression of metastasised breast cancer and DNA ploidy and S-phase fraction (SPF) of primary tumours was examined using paraffin-embedded tumour tissue from 81 patients....
Autores principales: | Hietanen, P., Blomqvist, C., Wasenius, V. M., Niskanen, E., Franssila, K., Nordling, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033766/ https://www.ncbi.nlm.nih.gov/pubmed/7734295 |
Ejemplares similares
-
Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.
por: Niskanen, E., et al.
Publicado: (1997) -
A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.
por: Sjöström, J., et al.
Publicado: (1998) -
The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study.
por: Kouri, M., et al.
Publicado: (1990) -
Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.
por: Muhonen, T., et al.
Publicado: (1992) -
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
por: Vesalainen, S., et al.
Publicado: (1994)